Primary analysis of data from Phase III trials of the AstraZeneca/Oxford #COVID19 vaccine has so far shown that it offers protection against severe di…


Primary analysis of data from Phase III trials of the AstraZeneca/Oxford #COVID19 vaccine has so far shown that it offers protection against severe disease, hospitalisation & death.
It is vital now to determine its effectiveness when it comes to preventing more severe illness.

Liked Liked